Total Funding
48
59
Total FundingPost-IPO Equity raised
Growth Score
-17 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
43095
Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.
Joel Sussman: Chief Financial OfficerPast Role: CDNOW, CFO
GEORGE D. HOBBS: SVP CORP. DEVELOPMENT AND GENERAL COUNSEL
About the Company
Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery. It features a software platform that enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens.
